DR. WONG CHEE KUAN
Department of Medicine
Faculty of Medicine
ckwongum.edu.myView CV | |
View 1-Page CV | |
Publons | |
Scopus Link | |
Biography | |
Dr. Wong Chee Kuan is a distinguished medical lecturer and consultant pulmonologist at the Universiti Malaya, specializing in respiratory diseases such as tuberculosis, COVID-19 pneumonia, asthma, chronic obstructive pulmonary disease (COPD) and lung cancer. He currently serves as the Head of the Division of Respiratory Medicine and the Chairman of the UMMC Tuberculosis (TB) Committee, where he has played a pivotal role in advancing the understanding and management of respiratory diseases. Dr. Wong earned his medical degree from Universiti Kebangsaan Malaysia (UKM) and obtained Membership of the Royal College of Physician (MRCP) in the United Kingdom. He further completed his fellowship in Respiratory Medicine at Universiti Malaya, cementing his expertise in the field. With a career spanning over a decade, Dr. Wong has made significant contributions to clinical research, medical education, and patient care. He is an active researcher and has published extensively in high-impact journals, addressing critical issues such as severe asthma, COPD, and long-term effects of COVID-19. His research efforts are supported by national and international funding bodies, including the World Health Organization (WHO) and the National Institute for Health Research (NIHR). Dr. Wong has led multiple clinical trials, contributing to advancement in respiratory medicine. In addition to his research, Dr. Wong is a passionate educator, supervising postgraduate students and mentoring future healthcare professionals. He has also contributed to the development of national TB clinical practice guidelines and serves on various professional committees, including the Malaysian Thoracic Society. A sought-after speaker and panelist, he frequently shares his expertise at conferences and workshop, both locally and internationally. Dr. Wong is committed to improving the quality of life for patients with respiratory diseases and aims to contribute toward eradicating tuberculosis by 2035 through his leadership, research, and advocacy.
|
Publication
Finance
Baseline predictors of mortality in non-idiopathic pulmonary fibrosis interstitial lung disease (Non-IPF ILD)
Association between ICS treatment and blood eosinophil level with interval between severe exacerbation events among COPD patients in Malaysia: EXACOS-MY study
Relationship between the use of ICS-containing therapy and the duration between severe exacerbations in COPD patients in Malaysia: EXACOSMY study
Diagnostic yield, detection of driver alterations by next-generation sequencing and safety of EBUS-guided mediastinal cryobiopsy versus needle aspiration: A retrospective comparative study
Guidelines on Performing Spirometry.
Patterns and trends in first-line anti-tuberculosis drug resistance in a major Malaysian tertiary teaching hospital over a 4-year period (2017-2020), International Journal of Infectious Diseases
Reasons for uncontrolled asthma in patients attending a difficult-to-treat asthma clinic
Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report
Relationship between PD‐L1 expression, common driver mutations and cigarette smoking in patients with non‐small cell lung cancer